Mira Pharmaceuticals, Common Stock Analysis
| MIRA Stock | 1.15 0.07 5.74% |
MIRA Pharmaceuticals, Common is undervalued with Real Value of 3.82 and Hype Value of 1.11. The main objective of MIRA Pharmaceuticals, stock analysis is to determine its intrinsic value, which is an estimate of what MIRA Pharmaceuticals, Common is worth, separate from its market price. There are two main types of MIRA Pharmaceuticals,'s stock analysis: fundamental analysis and technical analysis.
The MIRA Pharmaceuticals, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MIRA Pharmaceuticals,'s ongoing operational relationships across important fundamental and technical indicators.
MIRA |
MIRA Stock Analysis Notes
About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.55. MIRA Pharmaceuticals, had not issued any dividends in recent years. To find out more about MIRA Pharmaceuticals, Common contact Erez Aminov at 786 432 9792 or learn more at https://mirapharmaceuticals.com.MIRA Pharmaceuticals, Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MIRA Pharmaceuticals,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MIRA Pharmaceuticals, Common or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| MIRA Pharmaceuticals, had very high historical volatility over the last 90 days | |
| MIRA Pharmaceuticals, may become a speculative penny stock | |
| MIRA Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals, generates negative cash flow from operations | |
| MIRA Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 24.0% of the company outstanding shares are owned by corporate insiders |
MIRA Pharmaceuticals, Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MIRA Pharmaceuticals, previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of December 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
MIRA Pharmaceuticals, Thematic Classifications
In addition to having MIRA Pharmaceuticals, stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
MIRA Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.37 M.Technical Drivers
As of the 26th of March, MIRA Pharmaceuticals, secures the mean deviation of 3.93, and Risk Adjusted Performance of 0.0217. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of MIRA Pharmaceuticals,, as well as the relationship between them.MIRA Pharmaceuticals, Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MIRA Pharmaceuticals, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MIRA Pharmaceuticals,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MIRA Pharmaceuticals, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MIRA Pharmaceuticals, insiders, such as employees or executives, is commonly permitted as long as it does not rely on MIRA Pharmaceuticals,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MIRA Pharmaceuticals, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MIRA Pharmaceuticals, Predictive Daily Indicators
MIRA Pharmaceuticals, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MIRA Pharmaceuticals, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 42731.02 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 1.14 | |||
| Day Typical Price | 1.14 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.07) | |||
| Relative Strength Index | 43.29 |
MIRA Pharmaceuticals, Forecast Models
MIRA Pharmaceuticals,'s time-series forecasting models are one of many MIRA Pharmaceuticals,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MIRA Pharmaceuticals,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MIRA Pharmaceuticals, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |